| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	https://www.bloomberg.com/news/articles/2025-10-03/braskem-pulls-from-1-billion-credit-facility-amid-debt-review?srnd=homepage-...
 
																	Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...
 
																	Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...
 
																	UBS analyst Tasso Vasconcellos downgrades Braskem (NYSE: BAK) from Buy to Neutral and lowers the price target from $5.1 to $...
 
																	
 
																	JP Morgan analyst Ricardo Rezende maintains Braskem (NYSE:BAK) with a Neutral and lowers the price target from $6 to $5.
 
																	Braskem (NYSE:BAK) Q2 EPS $0.18 Up from $(0.48) YoY, Sales $3.152B Down from $3.659B YoY
 
																	